CoreCap Advisors’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.58K Buy
13
+12
+1,200% +$1.46K ﹤0.01% 2566
2026
Q2
$113 Hold
1
– – ﹤0.01% 3064
2026
Q1
$94 Sell
1
-2,696
-100% -$269K ﹤0.01% 2841
2025
Q4
$266K Sell
2,697
-2,046
-43% -$198K 0.01% 693
2025
Q3
$402K Buy
+4,743
New +$375K 0.01% 575
2025
Q2
– Sell
-3
Closed -$182 – 2993
2025
Q1
$182 Buy
+3
New +$209 ﹤0.01% 2996
2022
Q4
$232K Buy
+2,888
New +$221K 0.02% 501
2022
Q3
– Sell
-19,997
Closed -$1.52M – 1269
2022
Q2
$1.52M Buy
+19,997
New +$1.52M 0.12% 137
2022
Q1
– Sell
-50
Closed -$4K – 1269
2021
Q4
$4K Buy
+50
New +$3.37K ﹤0.01% 1802

Other funds holding INCY

CoreCap Advisors's INCY Position: Q3 2026 in Review

CoreCap Advisors increased its Incyte (INCY) stake by 1,200% in Q3 2026, buying an estimated $1.46K and bringing the position to 13 shares worth $1.58K. The position accounts for ﹤0.01% of the portfolio, ranked #2566.

CoreCap Advisors first reported a position in INCY in Q4 2021 and has held it in 9 quarters since. The position peaked at $1.52M in Q2 2022. 155 funds tracked by Wall St. Rank hold INCY as of Q3 2026.

  • CoreCap Advisors held 13 shares of Incyte worth $1.58K as of Q3 2026.
  • CoreCap Advisors bought 12 Incyte shares in Q3 2026, an estimated $1.46K.
  • Incyte made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2566 holding.
  • CoreCap Advisors first reported a position in Incyte in Q4 2021 and has held it in 9 quarters since.
  • CoreCap Advisors's Incyte position peaked at $1.52M in Q2 2022.
  • 155 funds tracked by Wall St. Rank held Incyte as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.